tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

APLM Stock Latest News

Apollomics announces results from Phase 3 bridging trial of uproleselan
The FlyApollomics announces results from Phase 3 bridging trial of uproleselan
2M ago
APLM
Apollomics Inc trading resumes
PremiumThe Fly
Apollomics Inc trading resumes
3M ago
APLM
Apollomics Inc trading halted, volatility trading pause
PremiumThe Fly
Apollomics Inc trading halted, volatility trading pause
3M ago
APLM
Apollomics regains compliance with Nasdaq minimum bid rule
PremiumThe Fly
Apollomics regains compliance with Nasdaq minimum bid rule
3M ago
APLM
Apollomics Inc trading resumes
PremiumThe Fly
Apollomics Inc trading resumes
3M ago
APLM
Apollomics Inc trading halted, volatility trading pause
PremiumThe FlyApollomics Inc trading halted, volatility trading pause
3M ago
APLM
Upcoming Stock Splits This Week (November 25 to November 29) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (November 25 to November 29) – Stay Invested
3M ago
PBM
APLM
Apollomics Inc trading halted, news pending
Premium
The Fly
Apollomics Inc trading halted, news pending
3M ago
APLM
Apollomics announces approval, date for 1-for-100 reverse share split
PremiumThe Fly
Apollomics announces approval, date for 1-for-100 reverse share split
3M ago
APLM
Apollomics presents Vebreltinib data in patients with NSCLC
PremiumThe Fly
Apollomics presents Vebreltinib data in patients with NSCLC
6M ago
APLM
Apollomics announces preliminary data on vebreltinib
PremiumThe Fly
Apollomics announces preliminary data on vebreltinib
7M ago
APLM
Apollomics announces changes in executive leadership team
PremiumThe Fly
Apollomics announces changes in executive leadership team
8M ago
APLM
Apollomics announces vebreltinib data at the 2024 ASCO meeting
PremiumThe FlyApollomics announces vebreltinib data at the 2024 ASCO meeting
9M ago
APLM
Apollomics price target lowered to $2 from $5 at H.C. Wainwright
Premium
The Fly
Apollomics price target lowered to $2 from $5 at H.C. Wainwright
10M ago
APLM
Apollomics announces approval of vebreltinib in China
Premium
The Fly
Apollomics announces approval of vebreltinib in China
10M ago
APLM
Apollomics presents vebreltinib data at AACR meeting
PremiumThe Fly
Apollomics presents vebreltinib data at AACR meeting
11M ago
APLM
Apollomics price target lowered to $5 from $17 at H.C. Wainwright
PremiumThe Fly
Apollomics price target lowered to $5 from $17 at H.C. Wainwright
11M ago
APLM
Apollomics reports FY23 EPS ($2.32) vs ($8.44) last year
PremiumThe Fly
Apollomics reports FY23 EPS ($2.32) vs ($8.44) last year
11M ago
APLM
Apollomics appoints Plunkett as CFO
PremiumThe Fly
Apollomics appoints Plunkett as CFO
12M ago
APLM
Apollomics receives Nasdaq notification regarding minimum bid price
PremiumThe FlyApollomics receives Nasdaq notification regarding minimum bid price
1y ago
APLM
Apollomics completes enrollment in Phase 3 bridging study of APL-106
Premium
The Fly
Apollomics completes enrollment in Phase 3 bridging study of APL-106
1y ago
APLM
GLYC
Apollomics presents interim data from ongoing Phase 2 trials with vebreltinib
Premium
The Fly
Apollomics presents interim data from ongoing Phase 2 trials with vebreltinib
1y ago
APLM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >